Cargando…

Factors determining chance of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a nationwide cohort study in 8057 Swedish patients

INTRODUCTION: Bariatric and metabolic surgery is an effective treatment option for type 2 diabetes (T2D). Increased knowledge regarding factors associated with diabetes remission is essential in individual decision making and could guide postoperative care. Therefore, we aimed to explore factors kno...

Descripción completa

Detalles Bibliográficos
Autores principales: Stenberg, Erik, Olbers, Torsten, Cao, Yang, Sundbom, Magnus, Jans, Anders, Ottosson, Johan, Naslund, Erik, Näslund, Ingmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127970/
https://www.ncbi.nlm.nih.gov/pubmed/33990366
http://dx.doi.org/10.1136/bmjdrc-2020-002033
_version_ 1783694035193430016
author Stenberg, Erik
Olbers, Torsten
Cao, Yang
Sundbom, Magnus
Jans, Anders
Ottosson, Johan
Naslund, Erik
Näslund, Ingmar
author_facet Stenberg, Erik
Olbers, Torsten
Cao, Yang
Sundbom, Magnus
Jans, Anders
Ottosson, Johan
Naslund, Erik
Näslund, Ingmar
author_sort Stenberg, Erik
collection PubMed
description INTRODUCTION: Bariatric and metabolic surgery is an effective treatment option for type 2 diabetes (T2D). Increased knowledge regarding factors associated with diabetes remission is essential in individual decision making and could guide postoperative care. Therefore, we aimed to explore factors known to affect the chance of achieving diabetes remission after bariatric and metabolic surgery and to further investigate the impact of socioeconomic factors. RESEARCH DESIGN AND METHODS: In this nationwide study, we assessed all patients with T2D who underwent Roux-en-Y gastric bypass (RYGB) surgery between 2007 and 2015 in the Scandinavian Obesity Surgery Registry. Remission was defined as absence of antidiabetic medication for T2D 2 years after surgery. Multivariable logistic regression was used to evaluate factors associated with diabetes remission, with missing data handled by multiple imputations. RESULTS: A total of 8057 patients were included. Mean age±SD was 47.4±10.1 years, mean body mass index 42.2±5.7 kg/m(2), mean hemoglobin A1c 59.0±17.33, and 61.7% (n=4970) were women. Two years after surgery, 6211 (77.1%) patients achieved T2D remission. Preoperative insulin treatment (OR 0.26, 95% CI 0.22 to 0.30), first-generation immigrant (OR 0.66, 95% CI 0.57 to 0.77), duration of T2D (OR 0.89, 95% CI 0.88 to 0.90), dyslipidemia (OR 0.71, 95% CI 0.62 to 0.81), age (OR 0.97, 95% CI 0.96 to 0.97), and high glycosylated hemoglobin A1c (HbA1c) (OR 0.99, 95% CI 0.98 to 0.99) were all associated with lower T2D remission rate. In contrast, residence in a medium-sized (OR 1.39, 95% CI 1.20 to 1.61) or small (OR 1.46, 95% CI 1.25 to 1.71) town and percentage of total weight loss (OR 1.04, 95% CI 1.03 to 1.04) were associated with higher remission rates. CONCLUSION: Among patients with T2D undergoing RYGB surgery, increasing age, HbA1c, and diabetes duration decreased the chance of reaching diabetes remission without cut-offs, while postoperative weight loss demonstrated a positive linear association. In addition, being a first-generation immigrant and living in a large city were socioeconomic factors having a negative association.
format Online
Article
Text
id pubmed-8127970
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-81279702021-05-26 Factors determining chance of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a nationwide cohort study in 8057 Swedish patients Stenberg, Erik Olbers, Torsten Cao, Yang Sundbom, Magnus Jans, Anders Ottosson, Johan Naslund, Erik Näslund, Ingmar BMJ Open Diabetes Res Care Clinical care/Education/Nutrition INTRODUCTION: Bariatric and metabolic surgery is an effective treatment option for type 2 diabetes (T2D). Increased knowledge regarding factors associated with diabetes remission is essential in individual decision making and could guide postoperative care. Therefore, we aimed to explore factors known to affect the chance of achieving diabetes remission after bariatric and metabolic surgery and to further investigate the impact of socioeconomic factors. RESEARCH DESIGN AND METHODS: In this nationwide study, we assessed all patients with T2D who underwent Roux-en-Y gastric bypass (RYGB) surgery between 2007 and 2015 in the Scandinavian Obesity Surgery Registry. Remission was defined as absence of antidiabetic medication for T2D 2 years after surgery. Multivariable logistic regression was used to evaluate factors associated with diabetes remission, with missing data handled by multiple imputations. RESULTS: A total of 8057 patients were included. Mean age±SD was 47.4±10.1 years, mean body mass index 42.2±5.7 kg/m(2), mean hemoglobin A1c 59.0±17.33, and 61.7% (n=4970) were women. Two years after surgery, 6211 (77.1%) patients achieved T2D remission. Preoperative insulin treatment (OR 0.26, 95% CI 0.22 to 0.30), first-generation immigrant (OR 0.66, 95% CI 0.57 to 0.77), duration of T2D (OR 0.89, 95% CI 0.88 to 0.90), dyslipidemia (OR 0.71, 95% CI 0.62 to 0.81), age (OR 0.97, 95% CI 0.96 to 0.97), and high glycosylated hemoglobin A1c (HbA1c) (OR 0.99, 95% CI 0.98 to 0.99) were all associated with lower T2D remission rate. In contrast, residence in a medium-sized (OR 1.39, 95% CI 1.20 to 1.61) or small (OR 1.46, 95% CI 1.25 to 1.71) town and percentage of total weight loss (OR 1.04, 95% CI 1.03 to 1.04) were associated with higher remission rates. CONCLUSION: Among patients with T2D undergoing RYGB surgery, increasing age, HbA1c, and diabetes duration decreased the chance of reaching diabetes remission without cut-offs, while postoperative weight loss demonstrated a positive linear association. In addition, being a first-generation immigrant and living in a large city were socioeconomic factors having a negative association. BMJ Publishing Group 2021-05-14 /pmc/articles/PMC8127970/ /pubmed/33990366 http://dx.doi.org/10.1136/bmjdrc-2020-002033 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical care/Education/Nutrition
Stenberg, Erik
Olbers, Torsten
Cao, Yang
Sundbom, Magnus
Jans, Anders
Ottosson, Johan
Naslund, Erik
Näslund, Ingmar
Factors determining chance of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a nationwide cohort study in 8057 Swedish patients
title Factors determining chance of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a nationwide cohort study in 8057 Swedish patients
title_full Factors determining chance of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a nationwide cohort study in 8057 Swedish patients
title_fullStr Factors determining chance of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a nationwide cohort study in 8057 Swedish patients
title_full_unstemmed Factors determining chance of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a nationwide cohort study in 8057 Swedish patients
title_short Factors determining chance of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a nationwide cohort study in 8057 Swedish patients
title_sort factors determining chance of type 2 diabetes remission after roux-en-y gastric bypass surgery: a nationwide cohort study in 8057 swedish patients
topic Clinical care/Education/Nutrition
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127970/
https://www.ncbi.nlm.nih.gov/pubmed/33990366
http://dx.doi.org/10.1136/bmjdrc-2020-002033
work_keys_str_mv AT stenbergerik factorsdeterminingchanceoftype2diabetesremissionafterrouxenygastricbypasssurgeryanationwidecohortstudyin8057swedishpatients
AT olberstorsten factorsdeterminingchanceoftype2diabetesremissionafterrouxenygastricbypasssurgeryanationwidecohortstudyin8057swedishpatients
AT caoyang factorsdeterminingchanceoftype2diabetesremissionafterrouxenygastricbypasssurgeryanationwidecohortstudyin8057swedishpatients
AT sundbommagnus factorsdeterminingchanceoftype2diabetesremissionafterrouxenygastricbypasssurgeryanationwidecohortstudyin8057swedishpatients
AT jansanders factorsdeterminingchanceoftype2diabetesremissionafterrouxenygastricbypasssurgeryanationwidecohortstudyin8057swedishpatients
AT ottossonjohan factorsdeterminingchanceoftype2diabetesremissionafterrouxenygastricbypasssurgeryanationwidecohortstudyin8057swedishpatients
AT naslunderik factorsdeterminingchanceoftype2diabetesremissionafterrouxenygastricbypasssurgeryanationwidecohortstudyin8057swedishpatients
AT naslundingmar factorsdeterminingchanceoftype2diabetesremissionafterrouxenygastricbypasssurgeryanationwidecohortstudyin8057swedishpatients